Columbus Nuc Med Radiopharmaceutical Meds

This is a SOURCES SOUGHT notice. Please note that this is not a request for proposal (RFP) or bids, and the government is seeking information for market research purposes only. No solicitation document is available. The Department of Veterans Affairs, Network Contracting Office (NCO) 10 is issuing this Sources Sought to identify potential experienced businesses that are capable of meeting the requirements per the Statement of Work (SOW) below. The response to this notice shall be in summary format, and shall not exceed two (2) pages. Please include the following:



Contractor shall also comply with any other federal, state, and local laws applicable to the industry. Potential sources must demonstrate experience, and knowledge of required services and capability to provide such services. Potential sources should submit:



Business name and address,

Point of contact,

DUNS Number

Business size, and any applicable business socio-economic category

Capabilities Statement to include at a minimum the following information:



Do you currently or have you had past experience providing Radiopharmaceuticals to the Department of Veterans Affairs? If so, how many VA Medical Centers did you support concurrently within a single contract? Which VISN?



Demonstrate your company s experience with supporting VA Medical Centers with Radiopharmaceuticals.



Demonstrated your company s ability to obtain and maintain required Nuclear Regulatory Commission (NRC) certifications.



Demonstrate your capabilities to provide or acquire the necessary resources (i.e. personnel, facilities, materials, transportation, equipment and communication services) to provide the required Radiopharmaceuticals.



Please indicate if your company can provide services for the Chalmers P. Wylie Ambulatory Care Center, Columbus, OH.



No basis for claim against the Government shall arise as a result of a response to this sources sought or Government use of any information provided. The Government will not pay for information or comments provided, and will not recognize any costs associated with submission of comments. There is no guarantee, expressed or implicit, that market research for this acquisition will result in a particular set-aside or sole source award, or any other guarantee of award or acquisition strategy.



Responses to this notice shall be e-mailed to Myron J Carson at Myron.Carson@va.gov. Telephone responses will not be accepted. Responses must be received in writing no later than 4:00 p.m., Friday, November 3, 2017. This notice is to assist the VA in determining sources only. THE VA IS NOT CURRENTLY SEEKING PRICING OR OFFERS OF ANY KIND. There is no guarantee, expressed or implicit, that the market research for this acquisition will result in a particular guarantee of award strategy. All information is to be provided on a voluntary basis at no charge to the Government.



























SCOPE OF WORK (SOW)



The Chalmers P. Wylie Ambulatory Care Center, Columbus, OH has a requirement for Radiopharmaceutical Isotopes for patient care. The Contractor is to provide Radiopharmaceutical products as listed herein, as requested by authorized VA Staff, in accordance with Public Law 104-262 and 38 USC 8153 in order to support the Chalmers P. Wylie Ambulatory Care Center, Columbus, OH. The NAICS code for this procurement is 325412.



DELIVERIES: Deliveries shall be made to:

Chalmers P. Wylie Ambulatory Care Center

Nuclear Medicine Service

420 N. James Rd.

Columbus, OH, 43219-1834



Contractor shall provide routine delivery and pick-up of items during the hours of 7:30 a.m. to 4:00 p.m., Monday through Friday, excluding federal holidays. Orders can be placed via telephone, fax or email by staff nuclear medicine technologists or physicians assigned to the Nuclear Medicine Service at the VAMC.



All routine deliveries of radiopharmaceuticals, ordered by 4:30 p.m. the previous day, shall be at the VA facility by 8:00 am the next business day. The order shall include the patient name and prescribed radiopharmaceutical.



Emergency and additional request orders may be made and shall be delivered within one (1) hour of placement of the order, 24 hours a day, 7 days a week.



Pre-calibrated doses should not expire within 1 hour of calibration time requested by the Nuclear Medicine Service.



Stat Orders (emergency doses ordered during normal business hours: 8:00 a.m. 4:30 p.m.) shall be delivered within one (1) hour of placement of the order.



The 10 Federal Holidays observed by the Federal Government are:



New Year s Day January 1

Martin Luther King s Birthday 3rd Monday in January

Presidents Day 3rd Monday in February

Memorial Day Last Monday in May

Independence Day July 4

Labor Day 1st Monday in September

Columbus Day 2nd Monday in October

Veterans Day November 11

Thanksgiving Day 4th Thursday in November

Christmas Day December 25th



The President of the United States of America may declare additional days as a Federal holiday, and if so, this holiday will automatically be added to the list above. When a holiday falls on a Sunday, the following Monday shall be observed as a Federal holiday. When a holiday falls on a Saturday, the preceding Friday shall be observed as a Federal Holiday.



All products provided under this contract shall meet all requirements of the Nuclear Regulatory Commission (NRC). All products provided under this contract shall be packaged, and shipped in accordance with the requirements of the NRC, and Department of Transportation (DOT). All products returned will also be packaged in accordance with the requirements of the NRC and DOT. All products provided under this contract shall be from an FDA approved source with an available NDC number from the manufacturer.



Compliance with all OSHA manufacturing, packaging and shipping regulations is required. The awardee shall provide a copy of Type A package certification, and certificates of DOT and OSHA training for couriers prior to commencement of the contract.



The contractor shall guarantee the quality of all radiopharmaceuticals. Quality control shall include percent tag, and MO99 breakthrough as appropriate. The Contractor shall provide Quality Control on each agent dispensed. Only those products that pass quality control may be sent to the VA. The Contractor shall provide complete documentation on Quality Control results upon request.



The contractor shall label all products to indicate the amount of radiopharmaceutical, preparation time, expiration time and date, and comply with specific facility requirements.



The contractor shall invoice at least once a month to the Nuclear Medicine Service indicating the purchase order number, period covered, billing date, name of preparation, quantity, and dollar amount. Each radiopharmaceutical dose shall be identified as a separate line item on the invoice. In addition to billing electronically, a hard copy will be sent to the Nuclear Medicine Department at: VAMC Columbus, 420 N. James Road, Columbus, Ohio, 43219-1834.



The contractor shall not add to the invoice the cost of overages. Any cost to replace damaged or incorrect products will be at the cost of the contractor. Replacements shall be received within 48 hours of notification by the VAMC.



The Contractor shall provide complete documentation of inventory, disposal and patient dose records, which documents compliance with NRC upon request.



RECALLED AND DEFECTIVE PRODUCTS: the Contractor will immediately notify the Contracting Officer of any recalls of product or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled/defective products at no cost to the Government. The Contractor may be liable for costs of processing recalls, i.e. administrative and clinical services to replace recalled/defective products.



It is preferred that where applicable the contractor will provide Low Enriched Uranium (LEU) sourced Tc products vice High Enriched Uranium (HEU) sourced. The contactor should indicate which products and in which years that products will come from LEU sources. It is expected that where applicable LEU sourced Tc products will be provided starting no later than during Option year one (1).



Period of Performance will be for one (1) year beginning from date of award for a period of 12 months.



Proposals will only be considered from Offerors that are licensed by the NRC, and who are regularly established in the business of providing radionuclides as called for in this Sources Sought document. Offerors shall provide copies of licenses and certification in response to this Sources Sought.





Annual Requirements List of Radiopharamceuticals



Item

#





Description/Part Number*



Estimated Yearly QTY



Unit

Price per Unit



Extended Amount

1

99M TC Sulfur Colloid: 1 to 6 Millicurie

26

EA





2

99M TC-MAA: 5 Millicurie

26

EA





3

99M Tc-HDP: 25 Millicuries

170

EA





4

99M TC-DTPA Aerosol: 60 Millicurie

26

EA





5

99M Tc Mebrofenin: 5 to 15 Millicuries

208

EA





6

99M TC-MAG-3 unit dose: 20 Millicurie

26

EA





7

99M TC-SESTAMIBI (CARDIOLITE): 10 to 35 Milli

curie

2000

EA





8

99M Tc-Sestamibi (generic): 10 to 35 millicurie

2000

EA





9

Gallium-67: 1 Millicurie

20

EA





10

201-THALLIUM CHLORIDE: 1 Millicurie

300

EA





11

111-In Capromab Pendetide: 3 to 7 Millicurie

5

EA





12

IN-111 OCTREOTIDE: 2 to 7 Millicurie

5

EA





13

IN-111 DTPA: 2 Millicurie

5

EA





14

99M TC-White Blood Cells: 25 Millicurie

10

EA





15

99M TC-O 4: 25 Millicurie

20

EA





16

99M TC Sources

6

EA





17

99m Tc- Linearity doses

4

EA







18

IN-111 White Blood Cells: per study (0.5 to 1 Millicurie)

10

EA





19

ADENOSINE In Saline/milligram

1170

EA





20

ULTRATAG KIT

20

EA





21

Adenosine (20 ml vial)

75

EA





22

Adenosine (30 ml vial)

40

EA





Estimated Total Dollar Value: